En Face OCT Imaging
Understanding En Face OCT
En face OCT works with the same scan data collected during a routine OCT exam, but presents that information in a completely different way. Understanding how it works helps explain why your specialist may find it useful alongside other imaging tools.
During a standard OCT scan, the device captures hundreds of closely spaced cross-sectional images called B-scans, which together form a three-dimensional block of data representing the full scanned area of the retina. Software then identifies the boundaries of specific retinal layers within that data block, such as the nerve fiber layer, the photoreceptor layer, or the retinal pigment epithelium (the RPE, a thin layer of cells that supports the photoreceptors above it). An en face image is created by extracting a horizontal slice at one chosen layer depth, showing the reflectivity pattern of that layer across the entire scanned area. The result is a bird's-eye view of one specific tissue layer.
Standard OCT produces cross-sectional views of the retina, similar to slicing through a layered cake and looking at it from the side. That view is excellent for measuring retinal thickness, detecting fluid, and evaluating structural integrity at a specific location. En face OCT, by contrast, presents a top-down view of a single layer, more like looking straight down at the surface of that same cake from above. This perspective makes it easier to see the full horizontal spread of a disease feature within one layer, and it can detect small lesions that might fall between individual B-scans on a cross-sectional scan.
One of the most useful aspects of en face OCT is the ability to examine different retinal and choroidal layers independently. Each layer provides distinct, clinically relevant information.
- The photoreceptor ellipsoid zone reveals the health and integrity of light-sensing cells, with dark areas indicating cell loss or disruption
- The RPE level shows patterns of cell loss, pigment migration, and deposits
- The outer retina level reveals drusen (small deposits that form under the retina) distribution and shape
- Deeper choroidal segmentation reveals vessel patterns and abnormalities within the layer beneath the retina
By selecting different layers, your specialist can isolate exactly what they need to evaluate for your specific condition.
En Face OCT in Age-Related Macular Degeneration
En face OCT is especially valuable in evaluating age-related macular degeneration (AMD), the leading cause of vision loss in older adults. It provides a detailed map of how AMD affects the macula, the central part of the retina responsible for sharp, detailed vision.
Geographic atrophy is an advanced form of dry AMD in which retinal cells gradually die off, leaving areas of tissue loss across the macula. En face OCT at the RPE and photoreceptor levels can map these atrophic areas with precision, showing exactly where cell loss has occurred and how large those areas are. This mapping is important not only for diagnosis but also for tracking how quickly the atrophy is progressing over time, which matters particularly now that treatments for geographic atrophy are available. Many clinical trials studying these treatments have used en face OCT measurements as a key way to evaluate whether a treatment is working.
In wet AMD, abnormal blood vessels grow beneath the retina in a process called choroidal neovascularization. En face OCT helps visualize the size and activity of these neovascular membranes and any associated atrophic changes. The top-down perspective shows the full lateral extent of the neovascular complex, information that helps guide decisions about anti-VEGF treatment (injections used to reduce the growth of abnormal blood vessels). En face OCT is also useful for detecting early transitions from dry to wet AMD, since subtle changes beneath the RPE may be more visible on en face views than on individual cross-sectional scans.
In early and intermediate AMD, drusen form as small deposits underneath the retina. Different types of drusen have distinct appearances on en face imaging at different layer depths, including soft drusen, reticular pseudodrusen (deposits that form above the RPE rather than below it), and calcified drusen. Mapping the type, size, and distribution of drusen across the macula helps our specialists assess the risk of AMD advancing to a more severe stage and guides decisions about how frequently to schedule monitoring visits.
Applications in Other Retinal Conditions
Beyond AMD, en face OCT provides useful information across a wide range of retinal diagnoses. The ability to isolate individual layers makes it a flexible tool for evaluating many different types of retinal disease.
En face OCT is helpful for evaluating diabetic retinopathy, the damage that high blood sugar causes to the small blood vessels of the retina over time. En face images at the vitreoretinal interface (the boundary between the retina and the gel-like vitreous in front of it) can reveal neovascular tissue growing on the retinal surface. Deeper segmentation can show areas of capillary dropout, where small blood vessels have been lost, and regions of retinal ischemia, meaning tissue that is not receiving adequate blood flow. The top-down view helps distinguish these neovascular changes from other conditions, such as epiretinal membranes (thin scar tissue on the retinal surface), that can sometimes look similar on cross-sectional scans alone.
The pachychoroid disease spectrum includes conditions such as central serous chorioretinopathy and pachychoroid neovasculopathy, which involve abnormalities of the choroidal blood vessels beneath the retina. En face OCT at choroidal segmentation levels reveals dilated choroidal vessels, called pachyvessels, and shows how they are distributed across the macula. This information helps clarify the relationship between choroidal abnormalities and the overlying retinal changes and helps distinguish pachychoroid conditions from other causes of fluid under the retina or abnormal vessel growth.
For patients with inherited retinal conditions such as retinitis pigmentosa, Stargardt disease, or cone dystrophies, en face OCT provides a detailed map of where photoreceptor cells remain healthy and where cell loss has occurred. En face imaging at the photoreceptor ellipsoid zone shows the exact boundaries of preserved cells across the macula, helping characterize the pattern and severity of damage. This information is useful for monitoring how a condition changes over time and for evaluating candidacy and response to emerging treatments such as gene therapy.
En face OCT is also valuable in several other macular conditions. In epiretinal membranes, en face imaging at the vitreoretinal interface shows the full extent and pattern of the membrane, including areas of traction and retinal wrinkling that may be difficult to appreciate on cross-sectional views alone. In macular holes, en face views help assess the size of the opening and surrounding tissue changes. The technology can also reveal characteristic patterns of medication-related retinal toxicity, such as the pericentral damage associated with long-term hydroxychloroquine use.
What to Expect During Imaging
For patients, en face OCT is a straightforward part of a retinal exam. Knowing what to expect can help you feel comfortable and prepared.
En face OCT does not require a separate procedure. The images are generated from the same OCT scan that is already part of a routine retinal examination. You will sit at the OCT machine with your chin resting on a support and your forehead against a padded band, and the scan takes only seconds. There is no contact with the eye and no discomfort involved. Pupil dilation may be recommended depending on the OCT device being used and the clinical question your specialist is trying to answer, since dilation generally improves image quality.
If your specialist shows you en face OCT images during your appointment, they will appear as grayscale or color-coded maps of a specific retinal layer. Brighter and darker areas reflect different levels of tissue reflectivity, which can indicate healthy structures or areas affected by disease. Your specialist will explain what the images show in the context of your specific condition. En face images are typically reviewed alongside standard cross-sectional OCT scans, fundus photographs, and other test results to build a complete picture of your retinal health.
Advantages and Limitations
En face OCT is a powerful addition to retinal imaging, but like all diagnostic tools, it works best when understood in context. Knowing both its strengths and its limitations helps explain why your specialist uses it alongside other tests rather than in place of them.
En face OCT offers several important advantages over cross-sectional imaging alone. It provides an intuitive, map-like view of disease features across the entire scanned area, making it easier to appreciate the full extent and distribution of retinal changes. It can detect small lesions that fall between individual B-scans on a standard cross-sectional scan. It allows independent evaluation of separate retinal layers, isolating disease features that might be obscured by overlapping structures in a side-view image. It also provides measurements of lesion area and shape that are useful for tracking changes over time and evaluating how well a treatment is working.
En face OCT image quality depends on the accuracy of the software algorithms that identify retinal layer boundaries. In eyes with significant pathology, such as large areas of atrophy, subretinal fluid, or retinal detachment, the automated segmentation can be inaccurate, which distorts the en face image. Manual correction is possible but time-consuming. Image quality is also affected by media opacities (such as cataracts), difficulty holding a steady gaze, and motion during the scan. Because of these factors, en face OCT is most informative when reviewed alongside cross-sectional B-scans, as the two perspectives together provide a more complete understanding of retinal health than either view alone.
Frequently Asked Questions
Here are answers to common questions about en face OCT and what it means for your care.
No separate appointment is needed. En face images are generated from the same volumetric data collected during your standard OCT scan, so no additional imaging session is required. Whether en face views are produced and reviewed depends on the OCT device available and whether your specialist finds them useful for your specific condition, but the process adds no extra time or discomfort to your visit.
Not necessarily. En face OCT is most helpful for specific conditions and clinical questions, such as mapping geographic atrophy, evaluating drusen distribution, or assessing the extent of photoreceptor loss. Your specialist will decide which imaging views are most informative based on your diagnosis and what they are monitoring over time. It is common for en face analysis to be used more selectively at certain visits rather than at every appointment.
In some cases, yes. Because en face imaging presents a top-down view of an entire retinal layer, it can reveal small lesions that fall between individual cross-sectional slices on a standard scan. It can also make certain disease patterns more visible by showing their full horizontal spread within a single layer. However, en face and cross-sectional OCT are complementary, not competing. Both views together give a more complete picture than either one alone, which is why specialists typically review both.
In most cases, no special preparation is needed. Your specialist may recommend pupil dilation before the scan to improve image quality, particularly if your pupils are small or if a deeper retinal structure needs to be evaluated. If dilation is planned, you should arrange for someone to drive you home, since your near vision and light sensitivity will be affected for several hours afterward. Otherwise, no fasting, medication changes, or other preparation is required.
Availability depends on the specific OCT device and software a practice uses. Most modern spectral-domain and swept-source OCT platforms are capable of generating en face images, and the technology is widely available at retinal specialty practices. If you are curious about whether en face imaging is part of your current care, it is worth asking your specialist directly about the imaging tools they use and how they apply them to your condition.
For patients receiving anti-VEGF injections for wet AMD, en face OCT helps your specialist visualize the full size and activity of the abnormal blood vessel complex beneath the retina, not just a single cross-sectional slice through it. This broader view can help clarify how well the treatment is working and whether any atrophic changes are developing alongside the neovascularization. That information contributes to decisions about treatment timing and frequency, which can vary from patient to patient.
Schedule Your Retinal Evaluation at Rhode Island Eye Institute
Our team of retinal specialists brings advanced imaging expertise and subspecialty training to every patient visit, combining tools like en face OCT with a thorough clinical evaluation to give you the clearest possible understanding of your retinal health. Whether you are managing a known condition or seeking a first opinion, we are here to help you navigate your care with confidence. We welcome patients from across Rhode Island and southeastern Massachusetts and look forward to supporting your vision for the long term.